Accelerated Combined Extraction & Sequencing Services

Genomics England is seeking to procure a partner to provide extraction and sequencing of between 30,000 and 65,000 whole genomes with a 7 day turnaround time. The Generation Study is the NHS-embedded research study delivered through the Newborn Genomes Programme and aims to explore the benefits, challenges, and practicalities of offering WGS to newborns, to accelerate diagnosis and access to treatment for rare genetic conditions. The Study is divided into two stages: Standard Turnaround Stage Sequencing of between 35,000 and 50,000 WGSs with the samples being processed by the Authority’s designated biorepository and then sequenced with the Authority’s current provider under the contract that provides for an end to end 28 -working-day turnaround time (TAT). Accelerated Delivery Stage Sequencing of between 30,000 and 65,000 WGSs with a target of an end to end 14-working-day TAT. Day 1 is the day the sample arrives at the sequencing provider with Day 14 being the delivery of the clinical results to the participant(s). The Authority believes that in order to achieve this, the sample extraction and sequencing work must be conducted in no more than 7 working days. This procurement is for the Accelerated Delivery Stage only. Suppliers interested in bidding should log on to the e-tendering portal https://genomicsengland.bravo.co.uk and register for the opportunity at project_856.